Abstract:OBJECTIVE:To study the inhibitory effect of small interference RNA (siRNA) targeting cyclin A2 gene on the growth of osteosarcoma MG-63 and human normal skin fibroblast HSF cells and to explore whether cyclin A2 siRNAs could become a useful tool in the treatment of osteosarcoma.METHODS:Three pairs of siRNAs targeting cyclin A2 mRNA and a pair of nonsense siRNA were designed according to the current criteria. SiRNAs were chemically synthesized and purified. The siRNAs were transfected into MG-63 cells and HSF cells via oligofectamine. The cells transfected with nonsense siRNA served as negative control group and those only treated with PBS as blank control group. Quantitative fluorescence RT-PCR, Western-blot, MTT assay, reverse transcriptase (RT)-PCR, flow cytometry and clone forming test were employed to evaluate the efficacy of RNA interference. At the same time, the mRNA expression of PCNA and cyclin B1 in siRNA-treated MG-63 cells were examined.RESULTS:Although all three siRNAs could reduce the cyclin A2 expression, siRNA, appeared to be the most effective. After 48 h treatment with siRNA1, cyclin A2 mRNA and protein expression in MG-63 cells was significantly reduced by nearly 80% as compared with that of the blank control group, whereas the negative and blank control groups had similar expression levels. MG-63 cells treated with siRNA1 were arrested at G0/G1 phase by 80.1% and the proliferation of these tumor cells was suppressed 48 h after transfection. Furthermore, MG-63 cells showed a decreased colony forming ability after siRNA1 treatment. In addition, the cyclin A2-depleted MG-63 cells showed decreased levels of PCNA and cyclin B1. In contrast, although cyclin A2 expression in HSF reduced by nearly 60% after treatment by siRNA1 for 48h, these cells exhibited only a slight change in cell cycling, and neither clear inhibition of proliferation nor impaired colony forming ability was observed.CONCLUSION:Cyclin A2 is critical for proliferation of MG-63 cells. Cyclin A2-siRNAs can induce obvious inhibition of cyclin A2 mRNA and protein expression in MG-63 and HSF cells, which consequently down-regulate the proliferation of MG-63 cells. There is little effect on the proliferation of siRNA-treated HSF cells. Those results indicate that siRNAs against cyclin A2 may become a potential antiproliferative tool in future antitumor therapy.

Experimental Study on siRNA Screening of Cathepsin K Gene and Construction of Its Plasmid Vector

Study of Cathepsin K Gene Inhibition on Cartilage Cell Function

Construction and identification of vector against Kir6.2 gene expression in hepatoma cells by short interfering RNAs

Enhanced Cartilage Formation by Inhibiting Cathepsin K Expression in Chondrocytes Expanded in Vitro

Role of RhoC-siRNA Expression Vector on Growth Velocity and Invasiveness of Hepatoma Carcinoma Cells

Construction of Cathepsin K Lentivirus Plasmid

Construction and Identification of a Small Interfering RNA Expression Vector for Depressing Chondroitin Sulfate Proteoglycans Versican V2 Gene Expression in Rat Neural Stem Cells

Construction of Targeting-Skp2 Shrna Plasmids and Observation of Their Inhibitory Effect on Tca8113 Cells

[Effect of Sirna-Cox-2 on the Growth Inhibition and Apoptosis of Cartilage Endplate Chondrocytes].

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

Design,synthesis and Activity Evaluation of Small Interfering RNA Targeting Connective Tissue Growth Factor

[Knockdown of Cyclin A2 Expression by Small Interfering RNA in MG-63 Cells].

A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system

Construction and Identification of Lentiviral Vector of Sirna Specific for CTGF

Lentivirus-mediated knockdown of aggrecanase-1 and -2 promotes chondrocyte-engineered cartilage formation in vitro.

Construction of Targeting-VEGF shRNA Plasmid and Observation of its Inhibitory Effect on Tca8113 Cells

Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation

Construction of an Expression Vector Carrying Short Hairpin RNA Targeting CK1α Gene and Its Effects on A549 Cells' Growth

Intra-articular delivery of anti-Hif-2α siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice

Construction and identification of siRNA expression vector targeting KDR

Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment